FDA Issues Nationwide Recall for Rheumatoid Arthritis Drug Tyenne Over Glass Particle Contamination

The FDA has announced a nationwide recall of Tyenne (tocilizumab-aazg) Injection vials, a rheumatoid arthritis medication. This action follows the discovery of glass particles in certain vials, posing serious health risks including potential blood clots, organ damage, or death if administered. Patients using lot number 16UI07, expiring 08/2028, are advised to check their medication.